Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 27
Filtrer
1.
Cell Death Differ ; 9(2): 199-208, 2002 Feb.
Article de Anglais | MEDLINE | ID: mdl-11840170

RÉSUMÉ

The Alzheimer amyloid precursor protein (APP) is a transmembrane protein whose abnormal processing is associated with the pathogenesis of Alzheimer's disease. Activated caspases cleave APP and generate its carboxyl-terminally truncated fragment (APPdeltaC31). We have previously reported that overexpression of wild-type APP induces caspase-3 activation and apoptosis in postmitotic neurons. We now report that APPdeltaC31 potentially plays pathophysiological roles in neuronal death. Adenovirus-mediated overexpression of wild-type APP695 induced activation of caspase-3 and accumulation of APPdeltaC31 in postmitotic neurons derived from human NT2 embryonal carcinoma cells, whereas an APP mutant lacking the Abeta(1-20) region induced neither caspase-3 activation nor APPdeltaC31 generation. Inhibition of caspase-3 suppressed the generation of APPdeltaC31 in APP-overexpressing neurons. Forced expression of APPdeltaC31 induced apoptotic changes of neurons and non-neuronal cells, but failed to activate caspase-3. The cytotoxicity of APPdeltaC31 was also dependent on the Abeta(1-20) region. These results suggest that accumulation of wild-type APP activates neuronal caspase-3 to generate APPdeltaC31 that mediates caspase-3-independent cell death.


Sujet(s)
Précurseur de la protéine bêta-amyloïde/métabolisme , Précurseur de la protéine bêta-amyloïde/physiologie , Apoptose , Caspases/métabolisme , Adenoviridae/génétique , Précurseur de la protéine bêta-amyloïde/composition chimique , Animaux , Technique de Western , Cellules COS , Caspase-3 , Caspases/physiologie , Milieux de culture sans sérum , Humains , Immunohistochimie , Mitose , Modèles biologiques , Neurones/cytologie , Neurones/enzymologie , Fragments peptidiques/métabolisme , Structure tertiaire des protéines , Cellules cancéreuses en culture
2.
Brain Res ; 918(1-2): 121-30, 2001 Nov 09.
Article de Anglais | MEDLINE | ID: mdl-11684050

RÉSUMÉ

The physiological role of amyloid precursor protein (APP), whose anomalous metabolite is a putative pathogen for Alzheimer disease, remains unclear. From the enhanced responsiveness to glutamate in cultured hippocampal neurons after the introduction of cDNA of APP695 (an isoform of APP dominant in human brain) using an adenovirus vector, we have recently raised the hypothesis that APP modulates neuronal sensitivity to glutamate. To test this hypothesis, we utilized here the unique effects of glutamate on the survival of different types of neurons. It is known that hippocampal neurons undergo deterioration in 24 h after application of glutamate in a dose-dependent manner. This vulnerability was increased in the cells transfected with adenovirus carrying cDNA of APP695. By contrast, it is known that cerebellar granule neurons require for their survival the supplementation of NMDA to the medium. The dose of NMDA required for survival was reduced after the transfection of the APP-adenovirus to cerebellar granule neurons. These enhancing effects of APP on the glutamate-induced vulnerability in hippocampal neurons and the glutamate (NMDA)-dependent survival in cerebellar neurons were blocked by glutamate receptor inhibitors, and were not seen after application of a control adenovirus carrying cDNA of beta-galactosidase. Since the effects of glutamate were enhanced in both directions, the hypothesis became more likely that one of the physiological functions of cellular APP is the regulation of glutamate receptors.


Sujet(s)
Précurseur de la protéine bêta-amyloïde/métabolisme , Encéphale/métabolisme , Survie cellulaire/physiologie , Acide glutamique/métabolisme , Neurones/métabolisme , Récepteurs au glutamate/métabolisme , Précurseur de la protéine bêta-amyloïde/génétique , Animaux , Encéphale/effets des médicaments et des substances chimiques , Mort cellulaire/effets des médicaments et des substances chimiques , Mort cellulaire/physiologie , Survie cellulaire/effets des médicaments et des substances chimiques , Cellules cultivées , Cervelet/effets des médicaments et des substances chimiques , Cervelet/métabolisme , ADN complémentaire/métabolisme , Relation dose-effet des médicaments , Agonistes des acides aminés excitateurs/pharmacologie , Antagonistes des acides aminés excitateurs/pharmacologie , Vecteurs génétiques , Acide glutamique/pharmacologie , Hippocampe/effets des médicaments et des substances chimiques , Hippocampe/métabolisme , Potentiels de membrane/effets des médicaments et des substances chimiques , Potentiels de membrane/physiologie , N-Méthyl-aspartate/pharmacologie , Neurones/effets des médicaments et des substances chimiques , Neuroprotecteurs/métabolisme , Neuroprotecteurs/pharmacologie , Neurotoxines/métabolisme , Neurotoxines/pharmacologie , Fragments peptidiques/génétique , Fragments peptidiques/métabolisme , Chlorure de potassium/pharmacologie , Rats , Récepteurs au glutamate/effets des médicaments et des substances chimiques
3.
Biochem Biophys Res Commun ; 287(2): 440-4, 2001 Sep 21.
Article de Anglais | MEDLINE | ID: mdl-11554748

RÉSUMÉ

Ischemic white matter lesions have been reported in rats after bilateral common carotid ligation (BCAL). Previously, comparing normotensive rats (WKY) with spontaneously hypertensive rats (SHR), we too found that sustained moderate ischemia with spontaneous hypertension accelerated the formation of ischemic white matter lesions. In this study, we explored the feasibility of gene therapy for lesioned white matter by means of an adenovirus vector expressing a reporter gene, LacZ. Using sham-operated and hypoperfused SHR as well as sham-operated and hypoperfused WKY, we demonstrated that (i) adenovirus vectors could deliver a foreign gene into oligodendrocytes and astrocytes in the cerebral white matter; (ii) the transduction efficiency was most effective in SHR after BCAL; and (iii) the level of alpha(V)-integrin was significantly correlated with adenoviral transduction efficiency.


Sujet(s)
Cortex cérébral/physiologie , Techniques de transfert de gènes , Récepteur vitronectine/métabolisme , Adenoviridae/génétique , Animaux , Astrocytes/physiologie , Astrocytes/virologie , Cortex cérébral/virologie , Vecteurs génétiques , Immunohistochimie , Mâle , Oligodendroglie/physiologie , Oligodendroglie/virologie , Oligopeptides/métabolisme , Rats , Rats de lignée SHR , Rats de lignée WKY , Transduction génétique/méthodes
4.
Gene ; 272(1-2): 173-9, 2001 Jul 11.
Article de Anglais | MEDLINE | ID: mdl-11470523

RÉSUMÉ

Necdin is a growth suppressor expressed predominantly in postmitotic neurons, and ectopic expression of this protein suppresses cell growth. Here we report that Necdin directly binds to specific DNA sequences and serves as a transcriptional repressor. Polyhistidine-tagged Necdin was used for selection of random-sequence oligonucleotides by polymerase chain reaction-based amplification. Necdin recognized guanosine (G)-rich sequences that encompass multiple G clusters and intervening mono- or di-nucleotides of A, T and C. These sequences, termed GN boxes, resemble multiply aligned forms of the canonical GC box which is recognized by Sp family members. Necdin directly bound to a GN box consisting of contiguous two GC boxes with four G clusters, but not to a single GC box with two G clusters, whereas Sp1 bound to both. In a reporter system using Drosophila Schneider Line 2 cells, Necdin repressed Sp1-dependent activity of mouse c-myc P1 promoter that contains a typical GN box. Deletion of the GN box from the c-myc P1 promoter or its conversion to the single GC box abolished the Necdin-dependent repression. These results suggest that Necdin modulates gene transcription via the GN box that is potentially recognized by GC box-targeting Sp family members.


Sujet(s)
Guanosine/métabolisme , Protéines de tissu nerveux/métabolisme , Protéines nucléaires/métabolisme , Animaux , Baculoviridae/génétique , Séquence nucléotidique , Sites de fixation/génétique , Lignée cellulaire , ADN/génétique , ADN/métabolisme , Protéines de liaison à l'ADN/génétique , Protéines de liaison à l'ADN/métabolisme , Régulation de l'expression des gènes , Gènes myc/génétique , Vecteurs génétiques/génétique , Guanosine/génétique , Luciferases/génétique , Luciferases/métabolisme , Souris , Protéines de tissu nerveux/génétique , Protéines nucléaires/génétique , Régions promotrices (génétique)/génétique , Liaison aux protéines , Protéines de fusion recombinantes/génétique , Protéines de fusion recombinantes/métabolisme , Protéines recombinantes/métabolisme , Facteur de transcription Sp1/métabolisme , Transcription génétique
5.
Brain Res Mol Brain Res ; 80(2): 219-27, 2000 Sep 15.
Article de Anglais | MEDLINE | ID: mdl-11038254

RÉSUMÉ

To elucidate the mechanism of neuronal death in Alzheimer's disease, we investigated the effects of overexpression of wild-type Alzheimer amyloid precursor protein (APP) on neuronal cells and glial cells in vivo. When an APP695-expressing adenovirus was injected into the dorsal hippocampal region, a number of neurons in remote areas were positively stained with anti-APP monoclonal antibody, and underwent severe degeneration from 3 to 7 days after viral inoculation. Most degenerating neurons were immunopositive with both APP and activated caspase-3, but some neurons that expressed activated caspase-3 were not expressing APP from 7 to 14 days after virus injection. In the neighborhood of the degenerating neurons, activated microglia/macrophages, which were identified by the phenotypic marker C3bi receptor (CD11b/c; OX-42), were observed, and some of them appeared to phagocytose the caspase-3-immunopositive degenerating neurons. In addition to microglia/macrophages, infiltrating leukocytes expressing CD45 or CD4 were also detected. These results suggest that the increased accumulation of APP induced not only caspase-3-mediated death machinery, but also inflammatory responses including microglial activation. These inflammatory responses might cause further neurodegeneration through the alternative pathway that might activate the caspase-3-mediated death machinery without APP expression.


Sujet(s)
Adenoviridae/génétique , Précurseur de la protéine bêta-amyloïde/génétique , Caspases/métabolisme , Vecteurs génétiques , Hippocampe/immunologie , Maladie d'Alzheimer/immunologie , Maladie d'Alzheimer/métabolisme , Animaux , Apoptose/immunologie , Benzimidazoles , Caspase-3 , Numération cellulaire , Encéphalite/enzymologie , Colorants fluorescents , Régulation de l'expression des gènes viraux , Hippocampe/cytologie , Hippocampe/enzymologie , Macrophages/immunologie , Mâle , Microglie/immunologie , Dégénérescence nerveuse/immunologie , Dégénérescence nerveuse/métabolisme , Neurones/cytologie , Neurones/enzymologie , Neurones/immunologie , Rats , Rat Wistar
6.
Gene ; 245(1): 185-91, 2000 Mar 07.
Article de Anglais | MEDLINE | ID: mdl-10713459

RÉSUMÉ

The necdin gene is expressed predominantly in postmitotic neurons and encodes a growth suppressor that interacts with the transcription factors E2F1 and p53. Human necdin gene (NDN) is maternally imprinted and located in Prader-Willi syndrome deletion region 15q11.2-q12. We isolated an NDN homologous sequence from a human genomic DNA library. The homologous sequence is overall 83% identical with necdin cDNA sequence, and possesses a short poly(A) stretch at the 3' end and direct repeats at both ends. Expression of the homologous sequence, which lacks a 5' promoter sequence, was undetected in cultured human cell lines. We mapped this sequence to chromosome 12q14-q21.1 by fluorescence in situ hybridization. These characteristics of the NDN-homologous sequence are consistent with those of processed pseudogenes. The information about the necdin pseudogene in the human genome will be useful for genetic studies on NDN-associated neurogenic disorders.


Sujet(s)
Molécules d'adhérence cellulaire/génétique , Pseudogènes/génétique , Séquence nucléotidique , Technique de Northern , Zébrage chromosomique , Cartographie chromosomique , Chromosomes humains de la paire 12/génétique , Clonage moléculaire , ADN/composition chimique , ADN/génétique , ADN/isolement et purification , Régulation de l'expression des gènes tumoraux , Gliome/génétique , Gliome/anatomopathologie , Humains , Hybridation fluorescente in situ , Données de séquences moléculaires , Nectines , Neuroblastome/génétique , Neuroblastome/anatomopathologie , ARN messager/génétique , Alignement de séquences , Analyse de séquence d'ADN , Cellules cancéreuses en culture
7.
J Neurochem ; 74(2): 659-68, 2000 Feb.
Article de Anglais | MEDLINE | ID: mdl-10646517

RÉSUMÉ

Brain-derived neurotrophic factor (BDNF), a member of the neurotrophins, promotes differentiation and survival and regulates plasticity of various types of neurons. BDNF binds to TrkB, a receptor tyrosine kinase, which results in the activation of a variety of signaling molecules to exert the various functions of BDNF. Shp-2, a Src homology 2 domain-containing cytoplasmic tyrosine phosphatase, is involved in neurotrophin signaling in PC12 cells and cultured cerebral cortical neurons. To examine the roles of Shp-2 in BDNF signaling in cultured rat cerebral cortical neurons, the wild-type and phosphatase-inactive mutant (C/S mutant) forms of Shp-2 were ectopically expressed in cultured neurons using recombinant adenovirus vectors. We found that several proteins tyrosine-phosphorylated in response to BDNF showed enhanced levels of tyrosine phosphorylation in cultured neurons infected with C/S mutant adenovirus in comparison with those infected with the wild-type Shp-2 adenovirus. In addition, in immunoprecipitates with anti-Shp-2 antibody, we also observed at least four proteins that displayed enhanced phosphorylation in response to BDNF in cultured neurons infected with the C/S mutant adenovirus. We found that the Shp-2-binding protein, brain immunoglobulin-like molecule with tyrosine-based activation motifs (BIT), was strongly tyrosine-phosphorylated in response to BDNF in cultured neurons expressing the C/S mutant of Shp-2. In contrast, the level of BDNF-induced phosphorylation of mitogen-activated protein kinase and coprecipitated proteins with anti-Trk and Grb2 antibodies did not show any difference between neurons infected with these two types of Shp-2. Furthermore, the survival effect of BDNF was enhanced by the wild type of Shp-2, although it was not influenced by the C/S mutant of Shp-2. These results indicated that in cultured cerebral cortical neurons Shp-2 is specifically involved in the regulation of several tyrosine-phosphorylated proteins, including BIT, in the BDNF signaling pathway. In addition, the phosphatase Shp-2 may not influence the level of BDNF-induced activation of mitogen-activated protein kinase in cultured cortical neurons. Further, Shp-2 may have potential to positively regulate BDNF-promoting neuronal survival.


Sujet(s)
Protéines adaptatrices de la transduction du signal , Antigènes de différenciation , Facteur neurotrophique dérivé du cerveau/physiologie , Cortex cérébral/métabolisme , Molécule d'adhérence cellulaire neurale L-1 , Phosphoprotéines/métabolisme , Protein Tyrosine Phosphatases/physiologie , Récepteurs immunologiques , Transduction du signal/physiologie , Tyrosine/métabolisme , Animaux , Cellules cultivées , Cortex cérébral/cytologie , Activation enzymatique/physiologie , Femelle , Protéine adaptatrice GRB2 , Protéines et peptides de signalisation intracellulaire , Mâle , Glycoprotéines membranaires/métabolisme , Mitogen-Activated Protein Kinases/métabolisme , Mutation/génétique , Mutation/physiologie , Molécules d'adhérence cellulaire neurales/métabolisme , Neurones/métabolisme , Phosphoric monoester hydrolases/métabolisme , Protein Tyrosine Phosphatase, Non-Receptor Type 11 , Protein Tyrosine Phosphatase, Non-Receptor Type 6 , Protein Tyrosine Phosphatases/génétique , Protéines/métabolisme , Rats , Rat Wistar , Récepteur trkA/métabolisme , Récepteur trkB/métabolisme
8.
Exp Cell Res ; 251(2): 442-51, 1999 Sep 15.
Article de Anglais | MEDLINE | ID: mdl-10471329

RÉSUMÉ

Neurons withdraw from the cell cycle immediately after differentiation from their proliferative precursors. E2F1, a principal transcription factor that promotes cell cycle progression, must be silenced in neurons. We investigated the E2F1 system in postmitotic neurons derived from murine embryonal carcinoma P19 cells. P19 cells highly expressed the E2F1 gene during neural differentiation, and enriched neurons contained a high abundance of E2F1 mRNA. In contrast, postmitotic neurons possessed extremely low levels of E2F1 protein as assessed by the electrophoretic mobility shift assay and Western blotting. A recombinant E2F1 fusion protein was ubiquitinated in vitro when incubated with neuronal lysates. In addition, treatment with the proteasome inhibitor MG132 increased the endogenous level of E2F1 protein in neurons. These results suggest that the ubiquitin-proteasome pathway contributes, at least in part, to the downregulation of E2F1 protein in postmitotic neurons. Adenovirus-mediated transfer of E2F1 cDNA into postmitotic neurons induced both bromodeoxyuridine incorporation and chromatin condensation, suggesting that deregulated E2F1 expression causes both aberrant S-phase entry and apoptosis of postmitotic neurons. Thus, downregulation of endogenous E2F1 protein in postmitotic neurons may be indispensable for the prevention of their reentry into the cell cycle.


Sujet(s)
Protéines de transport , Protéines du cycle cellulaire , Cycle cellulaire/physiologie , Protéines de liaison à l'ADN , Neurones/anatomopathologie , Facteurs de transcription/biosynthèse , Adenoviridae/génétique , Animaux , Apoptose , Carcinome embryonnaire , Différenciation cellulaire , Cysteine endopeptidases/effets des médicaments et des substances chimiques , Inhibiteurs de la cystéine protéinase/pharmacologie , Facteurs de transcription E2F , Facteur de transcription E2F1 , Régulation de l'expression des gènes , Techniques de transfert de gènes , Vecteurs génétiques , Leucine/analogues et dérivés , Leucine/pharmacologie , Leupeptines/pharmacologie , Souris , Mitose/physiologie , Complexes multienzymatiques/effets des médicaments et des substances chimiques , Proteasome endopeptidase complex , Maturation post-traductionnelle des protéines , ARN messager/analyse , Protéine-1 de liaison à la protéine du rétinoblastome , Phase S/physiologie , Facteur de transcription DP-1 , Facteurs de transcription/génétique , Cellules cancéreuses en culture , Ubiquitines/métabolisme
9.
Nucleic Acids Res ; 27(18): 3752-61, 1999 Sep 15.
Article de Anglais | MEDLINE | ID: mdl-10471746

RÉSUMÉ

The t(1;19) chromosomal translocation of pediatric pre-B cell leukemia produces chimeric oncoprotein E2a-Pbx1, which contains the N-terminal transactivation domain of the basic helix-loop-helix (bHLH) transcription factor, E2a, joined to the majority of the homeodomain protein, Pbx1. There are three Pbx family members, which bind DNA as heterodimers with both broadly expressed Meis/Prep1 homeo-domain proteins and specifically expressed Hox homeodomain proteins. These Pbx heterodimers can augment the function of transcriptional activators bound to adjacent elements. In heterodimers, a conserved tryptophan motif in Hox proteins binds a pocket on the surface of the Pbx homeodomain, while Meis/Prep1 proteins bind an N-terminal Pbx domain, raising the possibility that the tryptophan-interaction pocket of the Pbx component of a Pbx-Meis/Prep1 complex is still available to bind trypto-phan motifs of other transcription factors bound to flanking elements. Here, we report that Pbx-Meis1/Prep1 binds DNA cooperatively with heterodimers of E2a and MyoD, myogenin, Mrf-4 or Myf-5. As with Hox proteins, a highly conserved tryptophan motif N-terminal to the DNA-binding domains of each myogenic bHLH family protein is required for cooperative DNA binding with Pbx-Meis1/Prep1. In vivo, MyoD requires this tryptophan motif to evoke chromatin remodeling in the Myogenin promoter and to activate Myogenin transcription. Pbx-Meis/Prep1 complexes, therefore, have the potential to cooperate with the myogenic bHLH proteins in regulating gene transcription.


Sujet(s)
Site allostérique , Protéines de liaison à l'ADN/composition chimique , Protéines de liaison à l'ADN/métabolisme , Protéines à homéodomaine/métabolisme , Protéines tumorales/métabolisme , Protéines proto-oncogènes/métabolisme , Facteurs de transcription/métabolisme , Cellules 3T3 , Motifs d'acides aminés , Séquence d'acides aminés , Animaux , Séquence nucléotidique , Séquence conservée/génétique , ADN/génétique , ADN/métabolisme , Protéines de liaison à l'ADN/génétique , Dimérisation , Humains , Souris , Données de séquences moléculaires , Mutation , Protéine du site-1 d'intégration des virus myéloïdes écotropiques , Facteurs de régulation myogènes/composition chimique , Facteurs de régulation myogènes/génétique , Facteurs de régulation myogènes/métabolisme , Facteur de transcription-1 de la leucémie pré-B , Éléments de réponse/génétique , Facteurs de transcription/composition chimique , Facteurs de transcription/génétique , Activation de la transcription , Tryptophane/génétique , Tryptophane/métabolisme
10.
J Neurosci ; 19(16): 6955-64, 1999 Aug 15.
Article de Anglais | MEDLINE | ID: mdl-10436052

RÉSUMÉ

Forced overexpression of wild-type Alzheimer amyloid precursor protein (APP) causes postmitotic neurons to degenerate. Caspase-3 (CPP32) is a principal cell death protease involved in neuronal apoptosis during physiological development and under pathological conditions. Here, we investigated whether APP overexpression activates caspase-3 in human postmitotic neurons using adenovirus-mediated gene transfer. When a recombinant adenovirus vector expressing human wild-type APP695 was infected in vitro into neurally differentiated embryonal carcinoma NT2 cells, only postmitotic neurons underwent severe degeneration. Before neurodegeneration, full-length APP- and Abeta-immunoreactive peptides were accumulated in infected neurons, and caspase-3-like protease activity was markedly elevated. Western blot analysis revealed that activated caspase-3 subunits were generated in APP-accumulating neurons. Such neuronal caspase-3 activation was undetectable in NT2 neurons infected with beta-galactosidase-expressing adenovirus. Addition of the caspase-3 inhibitor acetyl-Asp-Glu-Val-Asp-aldehyde to the culture medium significantly reduced the severity of degeneration exhibited by APP-overexpressing neurons. Immunocytochemical analyses revealed that some APP-accumulating neurons contained activated caspase-3 subunits and exhibited the characteristics of apoptosis, such as chromatin condensation and DNA fragmentation. Activation of caspase-3 was also observed in vivo in rat hippocampal neurons infected with the APP-expressing adenovirus. These results suggest that wild-type APP is an intrinsic activator of caspase-3-mediated death machinery in postmitotic neurons.


Sujet(s)
Maladie d'Alzheimer/métabolisme , Précurseur de la protéine bêta-amyloïde/métabolisme , Caspases/métabolisme , Neurones/enzymologie , Adenoviridae/génétique , Animaux , Caspase-3 , Mort cellulaire/physiologie , Activation enzymatique , Techniques de transfert de gènes , Vecteurs génétiques , Humains , Neurones/anatomopathologie , Rats , Cellules cancéreuses en culture
11.
Mol Cell Neurosci ; 12(1-2): 65-78, 1998 Sep.
Article de Anglais | MEDLINE | ID: mdl-9770341

RÉSUMÉ

We have established a novel strategy for introducing exogenous Bcl-2 into neuronal cells that is mediated by Cre/loxP recombination using recombinant adenoviral vectors. An on/off-switching cassette for Bcl-2 (CALNLbcl-2) was designed to express Bcl-2 by recombinase Cre-mediated excisional deletion of a spacer DNA flanked by a pair of loxP sites. Exogenous Bcl-2 was clearly induced in PC12 cell lines carrying CALNLbcl-2 after infection with recombinant adenovirus producing recombinase Cre (AxCANCre). Dual infection with both AxCANCre and a recombinant adenovirus bearing CALNLbcl-2 showed efficient delivery of exogenous Bcl-2 into a hybrid motoneuronal cell line and primary chicken spinal motoneurons. The delivery of foreign Bcl-2 promoted survival of motoneurons in medium either containing or lacking trophic support. Thus, this strategy for delivery of exogenous Bcl-2 will be useful for studying neuronal death as well as for introducing foreign genes into postmitotic neurons under the control of recombinase Cre.


Sujet(s)
Adenoviridae , Integrases/métabolisme , Neurones/cytologie , Protéines proto-oncogènes c-bcl-2/génétique , Transduction génétique , Protéines virales , Infections à Adenoviridae/génétique , Animaux , Apoptose/physiologie , Embryon de poulet , Réplication de l'ADN , Régulation de l'expression des gènes viraux , Gènes viraux/physiologie , Humains , Rein/cytologie , Neurones/enzymologie , Neurones/virologie , Cellules PC12 , Rats , Protéines de fusion recombinantes/physiologie
12.
Gene ; 213(1-2): 65-72, 1998 Jun 15.
Article de Anglais | MEDLINE | ID: mdl-9630521

RÉSUMÉ

Necdin is a growth suppressor expressed in virtually all postmitotic neurons in the brain. The human necdin gene, NDN, is maternally imprinted and deleted in the Prader-Willi syndrome, a neurobehavioral contiguous gene disorder. Here, we isolated and characterized the human chromosomal necdin gene and its promoter region. The necdin gene is intronless, and it encodes a protein of 321 amino acid residues, four residues shorter than mouse Necdin. By fluorescence in-situ hybridization analysis, the necdin gene was localized to chromosome 15q11.2-q12 within the Prader-Willi syndrome deletion region. CpG islands were found in a region extending from the proximal 5'-flanking sequence to the protein coding region. The 5'-flanking sequence, which lacks canonical TATA and CAAT boxes, possessed a promoter activity in postmitotic neurons derived from murine embryonal carcinoma P19 cells. Methylation in vitro of HhaI CpG sites in the promoter region reduced the transcriptional activity. These results suggest that the necdin gene is silenced through methylation of the CpG island encompassing its promoter region.


Sujet(s)
Gènes , Protéines de tissu nerveux/génétique , Protéines nucléaires/génétique , Syndrome de Prader-Willi/génétique , Délétion de séquence , Séquence d'acides aminés , Animaux , Séquence nucléotidique , Carcinome embryonnaire/anatomopathologie , Ilots CpG , Méthylation de l'ADN , Femelle , Empreinte génomique , Humains , Hypothalamus/métabolisme , Hybridation in situ , Souris , Données de séquences moléculaires , Neurones/métabolisme , Régions promotrices (génétique) , Alignement de séquences , Similitude de séquences , Spécificité d'espèce , Transcription génétique , Cellules cancéreuses en culture
13.
J Neurosci ; 18(7): 2387-98, 1998 Apr 01.
Article de Anglais | MEDLINE | ID: mdl-9502800

RÉSUMÉ

In an attempt to elucidate the pathological implications of intracellular accumulation of the amyloid precursor protein (APP) in postmitotic neurons in vivo, we transferred APP695 cDNA into rat hippocampal neurons by using a replication-defective adenovirus vector. We first improved the efficiency of adenovirus-mediated gene transfer into neurons in vivo by using hypertonic mannitol. When a beta-galactosidase-expressing recombinant adenovirus suspended in 1 M mannitol was injected into a dorsal hippocampal region, a number of neurons in remote areas were positively stained, presumably owing to increased retrograde transport of the virus. When an APP695-expressing adenovirus was injected into the same site, part of the infected neurons in the hippocampal formation underwent severe degeneration in a few days, whereas astrocytes near the injection site showed no apparent degeneration. These degenerating neurons accumulated different epitopes of APP, and beta/A4 protein (Abeta)-immunoreactive materials were undetected in the extracellular space. A small number of degenerating neurons showed nuclear DNA fragmentation. Electron microscopic examinations demonstrated that degenerating neurons had shrunken perikarya along with synaptic abnormalities. Microglial cells/macrophages were often found in close proximity to degenerating neurons, and in some cases they phagocytosed these neurons. These results suggest that intracellular accumulation of wild-type APP695 causes a specific type of neuronal degeneration in vivo in the absence of extracellular Abeta deposition.


Sujet(s)
Adenoviridae , Précurseur de la protéine bêta-amyloïde/génétique , Techniques de transfert de gènes , Hippocampe/cytologie , Dégénérescence nerveuse/physiopathologie , Maladie d'Alzheimer/métabolisme , Précurseur de la protéine bêta-amyloïde/analyse , Animaux , Apoptose/physiologie , Biotine , Fragmentation de l'ADN , ADN complémentaire , Nucléotides désoxyuridyliques , Diurétiques osmotiques/pharmacologie , Épitopes/analyse , Espace extracellulaire/composition chimique , Expression des gènes , Mâle , Mannitol/pharmacologie , Microglie/physiologie , Microscopie électronique , Neurones/composition chimique , Neurones/cytologie , Neurones/effets des médicaments et des substances chimiques , Rats , Rat Wistar , Coloration et marquage , Synapses/physiologie , Synapses/ultrastructure
14.
Neuroreport ; 8(8): 2067-72, 1997 May 27.
Article de Anglais | MEDLINE | ID: mdl-9223103

RÉSUMÉ

Although the neurotoxicity of beta-amyloid peptide is well established, the cellular functions of amyloid precursor protein (APP) remain unclear. Using an adenoviral vector, we introduced cDNA encoding human APP holoprotein into rat hippocampal neurones in culture. Neurones expressing the membrane-bound form of APP showed greater responsiveness to applied glutamate than non-expressing control neurones, as revealed by Ca2+ fluorometry. This increased responsiveness was not the result of secreted APP, as confirmed by observations of closely spaced APP-expressing and non-expressing cells in the same culture dish. These data suggest that one function of APP may be the regulation of glutamate receptors in neurones.


Sujet(s)
Précurseur de la protéine bêta-amyloïde/biosynthèse , Acide glutamique/métabolisme , Neurones/physiologie , Infections humaines à adénovirus/métabolisme , Animaux , Technique de Western , Calcium/analyse , Calcium/métabolisme , Cellules cultivées , Colorants fluorescents , Fura-2 , Vecteurs génétiques , Hippocampe/cytologie , Hippocampe/métabolisme , Humains , Immunohistochimie , Neurones/métabolisme , Rats
15.
J Biol Chem ; 271(2): 918-24, 1996 Jan 12.
Article de Anglais | MEDLINE | ID: mdl-8557705

RÉSUMÉ

Necdin is a 325 amino acid residue protein encoded by a cDNA clone isolated from neurally differentiated embryonal carcinoma cells. In situ hybridization histochemistry revealed that necdin mRNA-containing cells in vivo coincided with postmitotic neurons in the mouse brain from early periods of neurogenesis until adulthood. To study the regulation of necdin gene expression, we have isolated and characterized the necdin gene from a mouse genomic DNA library. The necdin gene contains no intron, and its upstream region lacks canonical TATA and CAAT boxes. To assess promoter activity, the 5'-flanking sequence (844 base pairs) of the necdin gene was fused to the LacZ reporter gene and transiently transfected into retinoic acid-treated P19 embryonal carcinoma cells. Most of the transfectants expressing high levels of LacZ immunoreactivity were postmitotic neurons differentiated from P19 cells. Deletion analysis using luciferase reporter genes demonstrated that a neuron-restrictive core promoter is localized to positions -80 to -35, in which a G+C-rich domain and a putative binding site for transcription factors with PAS (per, arnt, and single-minded) dimerization domain are comprised. These results suggest that postmitotic neuron-restrictive expression of the necdin gene is mediated by the specific cis-acting elements and that this promoter is applicable to postmitotic neuron-targeted expression of various transgenic systems.


Sujet(s)
Foetus/métabolisme , Protéines de tissu nerveux/génétique , Neurones/métabolisme , Protéines nucléaires/génétique , Séquence d'acides aminés , Animaux , Séquence nucléotidique , Différenciation cellulaire/génétique , Délétion de gène , Régulation de l'expression des gènes au cours du développement , Souris , Données de séquences moléculaires , Protéines de tissu nerveux/métabolisme , Neurones/anatomopathologie , Protéines nucléaires/métabolisme , Régions promotrices (génétique)/génétique , Cellules cancéreuses en culture
16.
Biochem Biophys Res Commun ; 211(2): 438-46, 1995 Jun 15.
Article de Anglais | MEDLINE | ID: mdl-7794255

RÉSUMÉ

To determine cis-acting elements required for neuron specific expression of a necdin gene, we tried to use zebra fish assay system in vivo instead of cell lines in vitro. Various expression vectors carrying upstream sequences of necdin gene fused to MEKA (lacZ) gene as a reporter were injected into fertilized zebra fish embryos and then the expression of the reporter gene was analyzed by the whole mount immunochemical method. No promoter activity was obtained with a construct carrying sequence from -63 to +63 of the necdin gene, while promoter activity with preferential skin expression was obtained with a construct having sequence from -86 to +28. Further upstream sequence from -173 to +28 exhibited neuron specific expression as well as that from -845 to +63. These results indicate that a cis-acting element responsible for neuron specific expression is located in an 87bp sequence from -173 to -87 of necdin gene.


Sujet(s)
Éléments activateurs (génétique) , Protéines de l'oeil/biosynthèse , Expression des gènes , Protéines de tissu nerveux/biosynthèse , Protéines de tissu nerveux/génétique , Neurones/métabolisme , Protéines nucléaires/biosynthèse , Protéines nucléaires/génétique , Phosphoprotéines , Régions promotrices (génétique) , Séquences d'acides nucléiques régulatrices , Animaux , Animal génétiquement modifié , Lignée cellulaire , Amorces ADN , Embryon non mammalien/cytologie , Embryon non mammalien/métabolisme , Régulateurs des protéines G , Immunohistochimie , Données de séquences moléculaires , Protéines de tissu nerveux/analyse , Protéines nucléaires/analyse , Réaction de polymérisation en chaîne , Protéines de fusion recombinantes/biosynthèse , Danio zébré , beta-Galactosidase/biosynthèse
17.
J Biol Chem ; 267(14): 10031-8, 1992 May 15.
Article de Anglais | MEDLINE | ID: mdl-1374396

RÉSUMÉ

We have isolated cDNAs encoding a chicken homologue of MRF4 (cMRF4) in addition to chicken MyoD (CMD1) and myogenin (c-myogenin) described previously. In an attempt to understand the roles that cMRF4, CMD1, and c-myogenin play in chicken myogenesis, the effects of these factors on muscle-specific cis-elements identified in regulatory regions of myosin alkali light chain (MLC) genes were examined. The promoter analysis of some of MLC genes has revealed two sorts of muscle-specific positive regulatory elements to date, an enhancer located upstream of the adult type LC1 gene and a cis-element, termed an MLC box, conserved among promoters of various MLC genes. The LC1 enhancer was exclusively trans-activated by CMD1. Although c-myogenin also activated transcription driven by the LC1 promoter, it was suggested that c-myogenin requires a cis-element(s) other than the CMD1-responsive enhancer. Chicken MRF4 could not trans-activate any of the constructs containing the LC1 promoter. In contrast, the promoter of the embryonic L23 gene was trans-activated by all of the three factors. From deletion and mutation analysis, the MLC box was shown to be involved in their positive regulation. These results extend previous observations that individual myogenic regulatory factors exhibit different capabilities in transcriptional activation of muscle-specific genes by acting distinctively upon their regulatory elements.


Sujet(s)
ADN/génétique , Régulation de l'expression des gènes , Protéines du muscle/génétique , Muscles/physiologie , Facteurs de régulation myogènes , Myosines/génétique , Régions promotrices (génétique) , Séquences d'acides nucléiques régulatrices , Transcription génétique , Séquence d'acides aminés , Animaux , Séquence nucléotidique , Cellules cultivées , Embryon de poulet , Poulets , ADN/isolement et purification , Conversion des gènes , Données de séquences moléculaires , Protéine MyoD , Myogénine , Plasmides , ARN/génétique , ARN/isolement et purification , Rats , Similitude de séquences d'acides nucléiques , Transfection
18.
Symp Soc Exp Biol ; 46: 343-53, 1992.
Article de Anglais | MEDLINE | ID: mdl-1341047

RÉSUMÉ

By the analysis of cis and trans-acting element involved in transcriptional regulation of chicken myosin alkali light chain genes, we have identified the MLC box, muscle specific enhancer element and negative regulatory element. The MLC box is an essential element for the expression of MLC genes located at approximately 100 bp upstream from mRNA start sites. The core sequence of MLC box is similar to the consensus of actin gene CArG box and SRE of c-fos oncogene. In vitro DNA-protein binding assay has revealed that the MLC box, CArG box and SRE might bind to a common or a similar protein complex. CMD1, cMyogenin, and cMRF4 transactivate the promorter with an intact MLC box, but not the promoter lacking MLC box, indicating that the MLC box itself is transactivated by the myogenic regulatory factors. This transactivation must have been due to the indirect effect of the myogenic regulatory factors, because chicken myogenic factors do not bind to the MLC box. A cis element identified at about 150 bp upstream from the cap site of cardiac MLC gene suppresses the cardiac MLC gene expression in skeletal muscle cells but not in cardiac muscle cells. The protein(s) bound to NRE might be identical with one of proteins bound to SRE. NRE may block the function of MLC box and resultantly inhibits the expression of cardiac MLC1 gene in skeletal muscle cells. Skeletal muscle enhancer at -2 kb of skeletal MLC1f gene is composed of two subelements P and D, cooperative action between them is required for sufficient enhancer activity. CMD1 and myogenin bind to the enhancer sequences of skeletal MLC1 gene and MCK gene and transactivate these genes preferentially in skeletal muscle cells. In addition to the CMD1 responsible enhancer, another cis-element is required for transactivation of the MLC1f gene by cMyogenin. An E-box adjacent to MLC box may co-work with the enhancer to increase the expression of MLC1f gene. Muscle specific and developmentally regulated expression of MLC gene family is regulated by the combination of these cis and trans-acting elements.


Sujet(s)
Régulation de l'expression des gènes/physiologie , Muscles/embryologie , Myosines/génétique , Animaux , Séquence nucléotidique , Embryon de poulet , Éléments activateurs (génétique)/physiologie , Données de séquences moléculaires , Muscles/composition chimique , Transcription génétique/physiologie , Activation de la transcription/physiologie
19.
Differentiation ; 48(3): 183-9, 1991 Dec.
Article de Anglais | MEDLINE | ID: mdl-1804740

RÉSUMÉ

We have developed a method of marking of mouse cells by means of transfection of a foreign gene. The transgene chosen here was the plasmid pEF321CAT which contains the bacterial chloramphenicol acetyl transferase (CAT) gene linked to the promoter region of the human polypeptide chain elongation factor 1 alpha (hEF1 alpha) gene. Evaluation of the plasmid pEF321CAT as a cellular marker for mouse cells involved intensive examination of a transgenic mouse carrying pEF321CAT. The CAT gene was expressed in all tissues examined, demonstrating that the hEF1 alpha promoter was active in a wide range of mouse cells. The plasmid itself did not exert any harmful effect on the normal development of mice, and the CAT activity was immunohistologically detectable on sectioned tissues by the use of anti-CAT serum. When the plasmid was transferred into embryonal carcinoma (EC) cells and embryonic stem (ES) cells, the CAT gene was also found to be expressed constantly irrespective of their differentiation. These results demonstrated that the plasmid pEF321CAT can be used as a reliable and feasible cellular marker that would distinguish unequivocally the cells of each of genotype in chimeric tissues.


Sujet(s)
Chimère , Chloramphenicol O-acetyltransferase/génétique , Gènes bactériens , Facteurs élongation chaîne peptidique/génétique , Régions promotrices (génétique) , Vieillissement , Animaux , Blastocyste/physiologie , Lignée cellulaire , Chloramphenicol O-acetyltransferase/métabolisme , Développement embryonnaire et foetal , Femelle , Foetus/physiologie , Expression des gènes , Humains , Mâle , Souris , Souris transgéniques , Spécificité d'organe , Facteur-1 d'élongation de la chaîne peptidique , Facteurs élongation chaîne peptidique/métabolisme , Plasmides , Transfection
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...